Related Experiment Videos

Postantibiotic effect of imipenem, alone and in combination with amikacin, on Pseudomonas aeruginosa

A A Gerçeker1, G Otük

  • 1Department of Pharmaceutical Microbiology, Faculty of Pharmacy, University of Istanbul, Turkey.

Chemotherapy
|November 1, 1995
PubMed

Insights

This study examined the postantibiotic effect (PAE) of imipenem and amikacin on Pseudomonas aeruginosa. Combining these antibiotics resulted in a PAE that was roughly the sum of their individual effects, suggesting implications for dosing strategies.

Area of Science:

  • Microbiology
  • Pharmacology
  • Infectious Diseases

Background:

  • Pseudomonas aeruginosa is an opportunistic pathogen often associated with hospital-acquired infections.
  • Antimicrobial resistance in P. aeruginosa necessitates understanding drug efficacy and synergistic effects.
  • Postantibiotic effect (PAE) describes the delay in bacterial regrowth after antibiotic exposure.

Purpose of the Study:

  • To investigate the postantibiotic effect (PAE) of imipenem and amikacin, both alone and in combination, against clinical strains of Pseudomonas aeruginosa.
  • To determine if the combined PAE of imipenem and amikacin exhibits synergy or additivity.
  • To provide insights into optimizing antimicrobial dosing regimens for P. aeruginosa infections.

Main Methods:

  • Exposure of four clinical P. aeruginosa strains to imipenem and amikacin (individually and combined) for 1 hour during logarithmic growth.
  • Evaluation of bacterial regrowth following antibiotic exposure using viable counting after serial dilution.
  • Quantification of the postantibiotic effect (PAE) for each treatment condition.

Main Results:

  • Imipenem alone induced a PAE ranging from 0.7 to 1.55 hours.
  • Amikacin alone induced a PAE ranging from 0.65 to 2 hours.
  • The combination of imipenem and amikacin resulted in a PAE ranging from 1.6 to 2.65 hours, approximating the sum of individual effects.

Conclusions:

  • The combined postantibiotic effect of imipenem and amikacin against P. aeruginosa is roughly additive.
  • These findings suggest that the timing of drug administration in combination therapy may be crucial for maximizing therapeutic outcomes.
  • Understanding PAE in combination therapy can inform clinical strategies for treating P. aeruginosa infections.

Related Concept Videos